Browsing by Author Mamo, David

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 5 to 24 of 69 < previous   next >
Issue DateTitleAuthor(s)
2008The antipsychotic potential of l-stepholidine : a naturally occurring dopamine receptor D1 agonist and D2 antagonistNatesan, Sridhar; Reckless, Greg E.; Barlow, Karen B. L.; Odontiadis, John; Nobrega, Jose N.; Baker, Glen B.; George, Susan R.; Mamo, David; Kapur, Shitij
2010Are antipsychotic prescribing patterns different in older and younger adults? : a survey of 1357 psychiatric inpatients in TorontoSproule, Beth A.; Lake, Jennifer; Mamo, David; Uchida, Hiroyuki; Mulsant, Benoit H.
2009Benzodiazepine and antidepressant use in elderly patients with anxiety disorders : a survey of 796 outpatients in JapanUchida, Hiroyuki; Suzuki, Takefumi; Mamo, David; Mulsant, Benoit H.; Kikuchi, Toshiaki; Takeuchi, Hiroyoshi; Tomita, Masayuki; Watanabe, Koichiro; Yagi, Gohei; Kashima, Haruo
2008Brain region binding of the D2/3 agonist [11C]‐(+)‐PHNO and the D2/3 antagonist [11C] raclopride in healthy humansGraff-Guerrero, Ariel; Willeit, Matthaeus; Ginovart, Nathalie; Mamo, David; Mizrahi, Romina; Rusjan, Pablo; Vitcu, Irina; Seeman, Philip; Wilson, Alan A.; Kapur, Shitij
2012Cholinergic pathways and cognition in patients with schizophrenia : a pilot studyRajji, Tarek K.; Chow, Tiffany W.; Voineskos, Aristotle N.; Links, Kira A.; Miranda, Dielle; Mamo, David; Ismail, Zahinoor; Pollock, Bruce G.; Mulsant, Benoit H.
2010Clozapine and global cognition in schizophreniaRajji, Tarek K.; Uchida, Hiroyuki; Ismail, Zahinoor; Ng, Wenzie; Mamo, David; Remington, Gary; Pollock, Bruce G.; Mulsant, Benoit H.
2009Clozapine exposure and the impact of smoking and gender : a population pharmacokinetic studyNg, Wenzie; Uchida, Hiroyuki; Ismail, Zahinoor; Mamo, David; Rajji, Tarek K.; Remington, Gary; Sproule, Beth A.; Pollock, Bruce G.; Mulsant, Benoit H.; Bies, Robert R.
2010Complementary and alternative medicine in psychotic disordersHazra, Monica; Noh, Samuel; Boon, Heather; Taylor, Andree; Moss, Karen; Mamo, David
2009D2 receptor blockade by risperidone correlates with attention deficits in late-life schizophreniaUchida, Hiroyuki; Rajji, Tarek K.; Mulsant, Benoit H.; Kapur, Shitij; Pollock, Bruce G.; Graff-Guerrero, Ariel; Menon, Mahesh; Mamo, David
2008D2 receptor occupancy of olanzapine pamoate depot using positron emission tomography : an open-label study in patients with schizophreniaMamo, David; Kapur, Shitij; Keshavan, Matcheri; Laruelle, Marc; Taylor, Cindy C.; Kothare, Prajakti A.; Barsoum, Penny; McDonnell, David
2012Defining treatment-resistant schizophrenia and response to antipsychotics : a review and recommendationSuzuki, Takefumi; Remington, Gary; Mulsant, Benoit H.; Uchida, Hiroyuki; Rajji, Tarek K.; Graff-Guerrero, Ariel; Mimura, Masaru; Mamo, David
2012Delineating the functional neuroanatomy of illness denial or anosognosia in schizophreniaGerretsen, Philip; Graff-Guerrero, Ariel; Mamo, David; Pollock, Bruce G.; Menon, Mahesh
2007Differential effects of aripiprazole on D 2, 5-HT 2, and 5-HT 1A receptor occupancy in patients with schizophrenia : a triple tracer PET studyMamo, David; Graff-Guerrero, Ariel; Mizrahi, Romina; Shammi, Chekkera M.; Romeyer, Franvoise; Kapur, Shitij
2010Differentiating the cognitive profile of schizophrenia from that of Alzheimer disease and depression in late lifeTing, Christina; Rajji, Tarek K.; Ismail, Zahinoor; Tang-Wai, David F.; Apanasiewicz, Nina; Miranda, Dielle; Mamo, David; Mulsant, Benoit H.
2015Dopamine D 2/3 receptor availability in the striatum of antipsychotic-free older patients with schizophrenia : a [11 C]-raclopride PET studyNakajima, Shinichiro; Caravaggio, Fernando; Mamo, David; Mulsant, Benoit H.; Chung, Jun Ku; Plitman, Eric; Iwata, Yusuke; Gerretsen, Philip; Uchida, Hiroyuki; Suzuki, Takefumi; Mar, Wanna; Wilson, Alan A.; Houle, Sylvain; Graff-Guerrero, Ariel
2015Dopamine D 2/3 receptor occupancy following dose reduction is predictable with minimal plasma antipsychotic concentrations : an open-label clinical trialNakajima, Shinichiro; Uchida, Hiroyuki; Bies, Robert R.; Caravaggio, Fernando; Suzuki, Takefumi; Plitman, Eric; Mar, Wanna; Gerretsen, Philip; Pollock, Bruce G.; Mulsant, Benoit H.; Mamo, David; Graff-Guerrero, Ariel
2012Dopamine D2 receptor occupancy and cognition in schizophrenia : analysis of the CATIE dataSakurai, Hitoshi; Bies, Robert R.; Stroup, Scott T.; Keefe, Richard S. E.; Rajji, Tarek K.; Suzuki, Takefumi; Mamo, David; Pollock, Bruce G.; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki
2012Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia : a cross-sectional studyMizuno, Yuya; Bies, Robert R.; Remington, Gary; Mamo, David; Suzuki, Takefumi; Pollock, Bruce G.; Tsuboi, Takashi; Watanabe, Koichiro; Mimura, Masaru; Uchida, Hiroyuki
2013Dopamine D2/3 occupancy of ziprasidone across a day : a within-subject PET studySuzuki, Takefumi; Graff-Guerrero, Ariel; Uchida, Hiroyuki; Remington, Gary; Caravaggio, Fernando; Borlido, Carol; Pollock, Bruce G.; Mulsant, Benoit H.; Deluca, Vincenzo; Ismail, Zahinoor; Mamo, David
2009Dosing of antipsychotics in schizophrenia across the life-spectrumUchida, Hiroyuki; Mamo, David